0000-0001-8589-3087 Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (10)
- Liberalizing hospital proximity requirements for children/young adults with low-burden B-ALL receiving tisagenlecleucel Save
- HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL Save
- Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium Save
- Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia Save
- Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia Save
- Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy Save
- Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report Save
- Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report Save
- Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia Save
- Caring without sharing: Meta-analysis 2.0 for massive genome-wide association studies Save